Modulating the Er:YAG laser.
OBJECTIVE
In the past 2 years, there has been some controversy about the optimal laser system, or combination of systems, for cutaneous resurfacing. Initially, it seemed that the Er:YAG laser would have significant advantages over the CO(2) laser. In practice, some of those who jumped early onto the Er:YAG bandwagon have been unimpressed with the degree of skin tightening that can be achieved with this system. Also, the excessive bleeding induced by the Er:YAG lasers prevented deeper vaporization. During the past 18 months, three new "modulated" Er:YAG lasers have been produced that are said to be able to achieve CO(2) laser-like effects, while maintaining the Er:YAG laser advantages. The purpose of this article is to examine these new systems and to discuss their potential benefits, if any, over the "conventional" Er:YAG lasers, and the CO(2) lasers.


METHODS
The author has collected data from his own experience and that of his colleagues in the department of dermatology at University of California at San Francisco. The author has used all three types of modulated Er:YAG laser on patients presenting for cosmetic laser resurfacing and the treatment of many benign conditions over an 18-month period.


RESULTS
All three modulated forms of Er:YAG lasers have been demonstrated to provide better coagulation than the conventional Er:YAG lasers. The Derma-K and the Contour Er:YAG lasers were able to induce tissue contraction/desiccation similar to the CO(2) laser. The author and his colleagues have induced only two cases of permanent hypopigmentation in over 50 cases during the past 18 months while using the Er:YAG laser, significantly less than might be expected with the CO(2) lasers.


CONCLUSIONS
If a laser surgeon is happy with the results obtained with a high-energy, short-pulse CO(2) laser, then there seems little reason to consider changing to an Er:YAG laser. The modulated Er:YAG lasers have definite advantages over the conventional Er:YAG lasers. They exhibit better control of hemostasis and can ablate tissue to a greater depth than the conventional Er:YAG lasers. The Er:YAG lasers might induce less permanent hypopigmentation than the CO(2) lasers.
Zachary
C B
CB
Department of Dermatology, Dermatologic Surgery and Laser Center, UCSF, San Francisco, California 94115, USA.
D062109:Dermatologic Surgical Procedures; D004871:Erbium; D006358:Hot Temperature / Q000009:adverse effects; D006801:Humans; D053685:Laser Therapy / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods; D007834:Lasers / Q000009:adverse effects*; D010859:Pigmentation Disorders / Q000209:etiology*; D015361:Rhytidoplasty / Q000379:methods*; D012867:Skin / Q000293:injuries*; D015595:Skin Aging; D016896:Treatment Outcome
D004871:Erbium